| 695.0 |
Toxic erythema |
| 695.10 |
Erythema multiforme, unspecified |
| 695.11 |
Erythema multiforme minor |
| 695.12 |
Erythema multiforme major |
| 695.13 |
Stevens-Johnson syndrome |
| 695.14 |
Stevens-Johnson syndrome-toxic epidermal necrolysis overlap syndrome |
| 695.15 |
Toxic epidermal necrolysis |
| 695.2 |
Erythema nodosum |
| 695.3 |
Rosacea |
| 695.4 |
Lupus erythematosus |
| 695.50 |
Exfoliation due to erythematous condition involving less than 10 percent of body surface |
| 695.51 |
Exfoliation due to erythematous condition involving 10-19 percent of body surface |
| 695.52 |
Exfoliation due to erythematous condition involving 20-29 percent of body surface |
| 695.53 |
Exfoliation due to erythematous condition involving 30-39 percent of body surface |
| 695.54 |
Exfoliation due to erythematous condition involving 40-49 percent of body surface |
| 695.55 |
Exfoliation due to erythematous condition involving 50-59 percent of body surface |
| 695.56 |
Exfoliation due to erythematous condition involving 60-69 percent of body surface |
| 695.57 |
Exfoliation due to erythematous condition involving 70-79 percent of body surface |
| 695.58 |
Exfoliation due to erythematous condition involving 80-89 percent of body surface |
| 695.59 |
Exfoliation due to erythematous condition involving 90 percent or more of body surface |
| 695.81 |
Ritter's disease |
| 695.89 |
Other specified erythematous conditions |
| 695.9 |
Unspecified erythematous condition |